194:
in 1979, and completed his postdoctoral fellowship with the
Ontario Cancer Institute in 1983. He then began his career in Switzerland and Austria. In 1990, he moved to the United States. Initially, Keller was at the National Jewish Centre for Immunology and Respiratory Medicine in Denver, CO and
748:
385:
493:
Nostro MC, Sarangi F, Ogawa S, Holtzinger A, Corneo B, Li X, Micallef SJ, Park IH, Basford C, Wheeler MB, Daley GQ, Elefanty AG, Stanley EG, Keller G (2011).
287:
773:
788:
783:
361:
163:
115:
495:"Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells"
778:
753:
626:"T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures"
544:"Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages"
768:
312:
743:
409:
Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G (1998). "A common precursor for hematopoietic and endothelial cells".
738:
196:
199:
in New York City, NY. In 2007, Keller returned to Canada to assume his current role and established his laboratory at the
667:"Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells"
183:
84:
56:
123:
155:
127:
70:
446:"An endothelial cell niche induces hepatic specification through dual repression of Wnt and Notch signaling"
200:
758:
175:
74:
279:
191:
159:
151:
144:
119:
88:
52:
763:
234:
Currently, the Keller group's research includes the differentiation of pluripotent stem cells to the
228:
349:
624:
Kennedy M, Awong G, Sturgeon CM, Ditadi A, LaMotte-Mohs R, Zúñiga-Pflücker JC, Keller G (2012).
282:
in
Embryonic Stem Cell Biology (2013-2020). He serves on the Scientific Advisory Boards of the
696:
647:
606:
583:
Craft AM, Ahmed N, Rockel JS, Baht GS, Alman BA, Kandel RA, Grigoriadis AE, Keller GM (2013).
565:
524:
475:
426:
215:
In 1997, Keller's team was the first to successfully isolate the developmentally significant
686:
678:
637:
596:
555:
514:
506:
465:
457:
418:
224:
362:"Behind the Breakthrough Podcast - University Health Network Season 4 - Dr. Gordon Keller"
691:
666:
519:
494:
470:
445:
397:
255:
243:
732:
263:
220:
216:
204:
714:
259:
179:
286:
and
Stemgent, and is also a founding member and past president (2005-2006) of the
642:
625:
560:
543:
239:
585:"Specification of chondrocytes and cartilage tissues from embryonic stem cells"
251:
247:
235:
187:
700:
651:
610:
569:
528:
479:
430:
422:
386:"Saskatchewan native Dr. Gordon Keller, a leader in regenerative medicine"
207:
for the development of iPSC-derived cells for clinical transplantation.
601:
584:
510:
267:
203:. In 2016, Keller co-founded Toronto-based BlueRock Therapeutics with
182:
and was raised on a farm. He completed his
Bachelor of Science at the
682:
461:
337:
313:"The 2019 Ogawa-Yamanaka Stem Cell Prize Awarded to Gordon Keller"
143:
is a
Canadian scientist recognized for his research on applying
444:
Han S, Dziedzic N, Gadue P, Keller GM, Gouon-Evans V (2011).
219:—a multipotent precursor cell that can differentiate to the
665:
Sturgeon CM, Ditadi A, Awong G, Kennedy M, Keller G (2014).
154:
differentiation. He is currently a Senior
Scientist at the
336:
290:. In addition, he is a senior editor for the journal
284:
283:
111:
103:
80:
62:
48:
40:
28:
21:
8:
398:"Honorary Doctor of Science - Gordon Keller"
288:International Society for Stem Cell Research
749:Academic staff of the University of Toronto
201:MaRS Centre/Toronto Medical Discovery Tower
18:
690:
641:
600:
559:
518:
469:
542:Kattman SJ, Huber TL, Keller GM (2006).
107:Stem cell biology, Developmental biology
303:
164:McEwen Centre for Regenerative Medicine
116:McEwen Centre for Regenerative Medicine
350:"Research Profile: Gordon Keller, PhD"
332:
330:
328:
326:
92:Ogawa-Yamanaka Stem Cell Prize (2019)
7:
311:Langelier, Julie (July 31, 2019).
14:
774:University of Saskatchewan alumni
789:21st-century Canadian biologists
784:20th-century Canadian scientists
338:"Lead Scientist: Gordon Keller"
197:Mount Sinai School of Medicine
35:Melville, Saskatchewan, Canada
16:Canadian biologist (born 1952)
1:
85:25 Transformational Canadians
779:University of Alberta alumni
754:Scientists from Saskatchewan
643:10.1016/j.celrep.2012.11.003
561:10.1016/j.devcel.2006.10.002
130:University of Alberta, Ph.D.
396:University of Saskatchewan
250:progenitors; as well as to
174:Keller was born in 1952 in
805:
348:University Health Network
186:. He completed his PhD in
184:University of Saskatchewan
57:University of Saskatchewan
134:
124:University Health Network
96:
162:and the director of the
156:Ontario Cancer Institute
128:Ontario Cancer Institute
769:Scientists from Toronto
744:Canada Research Chairs
278:Keller holds a Tier I
75:pluripotent stem cells
739:Stem cell researchers
423:10.1242/dev.125.4.725
280:Canada Research Chair
192:University of Alberta
160:University of Toronto
158:, a Professor at the
152:pluripotent stem cell
145:developmental biology
120:University of Toronto
89:Canada Research Chair
53:University of Alberta
23:Gordon Michael Keller
671:Nature Biotechnology
384:The Globe and Mail
229:embryonic stem cell
211:Scientific research
195:later moved to the
719:: Editorial Board"
602:10.1242/dev.087890
548:Developmental Cell
511:10.1242/dev.055236
595:(12): 2597–2610.
138:
137:
98:Scientific career
44:Canadian/American
796:
723:
722:
711:
705:
704:
694:
683:10.1038/nbt.2915
662:
656:
655:
645:
636:(6): 1722–1735.
621:
615:
614:
604:
580:
574:
573:
563:
539:
533:
532:
522:
490:
484:
483:
473:
462:10.1002/stem.576
441:
435:
434:
406:
400:
394:
388:
382:
376:
375:
373:
371:
366:
358:
352:
346:
340:
334:
321:
320:
308:
225:endothelial cell
141:Gordon M. Keller
19:
804:
803:
799:
798:
797:
795:
794:
793:
729:
728:
727:
726:
713:
712:
708:
664:
663:
659:
623:
622:
618:
582:
581:
577:
541:
540:
536:
492:
491:
487:
443:
442:
438:
408:
407:
403:
395:
391:
383:
379:
369:
367:
364:
360:
359:
355:
347:
343:
335:
324:
310:
309:
305:
300:
276:
213:
172:
126:
122:
118:
91:
87:
71:differentiation
55:
49:Alma mater
36:
33:
24:
17:
12:
11:
5:
802:
800:
792:
791:
786:
781:
776:
771:
766:
761:
756:
751:
746:
741:
731:
730:
725:
724:
706:
677:(6): 554–561.
657:
616:
575:
554:(5): 723–732.
534:
505:(5): 861–871.
485:
456:(2): 217–228.
436:
417:(4): 725–732.
401:
389:
377:
353:
341:
322:
302:
301:
299:
296:
275:
272:
256:cardiomyocytes
244:cholangiocytes
212:
209:
171:
168:
136:
135:
132:
131:
113:
109:
108:
105:
101:
100:
94:
93:
82:
78:
77:
64:
63:Known for
60:
59:
50:
46:
45:
42:
38:
37:
34:
30:
26:
25:
22:
15:
13:
10:
9:
6:
4:
3:
2:
801:
790:
787:
785:
782:
780:
777:
775:
772:
770:
767:
765:
762:
760:
759:Living people
757:
755:
752:
750:
747:
745:
742:
740:
737:
736:
734:
720:
718:
710:
707:
702:
698:
693:
688:
684:
680:
676:
672:
668:
661:
658:
653:
649:
644:
639:
635:
631:
627:
620:
617:
612:
608:
603:
598:
594:
590:
586:
579:
576:
571:
567:
562:
557:
553:
549:
545:
538:
535:
530:
526:
521:
516:
512:
508:
504:
500:
496:
489:
486:
481:
477:
472:
467:
463:
459:
455:
451:
447:
440:
437:
432:
428:
424:
420:
416:
412:
405:
402:
399:
393:
390:
387:
381:
378:
363:
357:
354:
351:
345:
342:
339:
333:
331:
329:
327:
323:
318:
317:gladstone.org
314:
307:
304:
297:
295:
293:
289:
285:
281:
273:
271:
269:
265:
264:T lymphocytes
261:
257:
253:
249:
245:
241:
237:
232:
230:
226:
222:
221:hematopoietic
218:
217:hemangioblast
210:
208:
206:
205:Lorenz Studer
202:
198:
193:
189:
185:
181:
177:
169:
167:
165:
161:
157:
153:
150:
146:
142:
133:
129:
125:
121:
117:
114:
110:
106:
102:
99:
95:
90:
86:
83:
79:
76:
72:
68:
65:
61:
58:
54:
51:
47:
43:
39:
32:November 1952
31:
27:
20:
716:
709:
674:
670:
660:
633:
630:Cell Reports
629:
619:
592:
588:
578:
551:
547:
537:
502:
498:
488:
453:
449:
439:
414:
410:
404:
392:
380:
368:. Retrieved
356:
344:
316:
306:
291:
277:
270:precursors.
260:chondrocytes
254:cell fates:
233:
231:technology.
227:fates—using
214:
180:Saskatchewan
173:
148:
147:findings to
140:
139:
112:Institutions
97:
66:
764:1952 births
717:Development
589:Development
499:Development
411:Development
370:14 December
292:Development
240:hepatocytes
41:Nationality
733:Categories
450:Stem Cells
298:References
252:mesodermal
248:pancreatic
236:endodermal
188:Immunology
238:lineage:
170:Biography
69:directed
701:24837661
652:23219550
611:23715552
570:17084363
529:21270052
480:21732480
176:Melville
149:in vitro
67:In vitro
692:4152856
520:3035090
471:3437666
431:9435292
274:Honours
268:myeloid
190:at the
699:
689:
650:
609:
568:
527:
517:
478:
468:
429:
104:Fields
81:Awards
365:(PDF)
697:PMID
648:PMID
607:PMID
566:PMID
525:PMID
476:PMID
427:PMID
372:2023
266:and
246:and
223:and
29:Born
687:PMC
679:doi
638:doi
597:doi
593:140
556:doi
515:PMC
507:doi
503:138
466:PMC
458:doi
419:doi
415:125
73:of
735::
695:.
685:.
675:32
673:.
669:.
646:.
632:.
628:.
605:.
591:.
587:.
564:.
552:11
550:.
546:.
523:.
513:.
501:.
497:.
474:.
464:.
454:29
452:.
448:.
425:.
413:.
325:^
315:.
294:.
262:,
258:,
242:,
178:,
166:.
721:.
715:"
703:.
681::
654:.
640::
634:2
613:.
599::
572:.
558::
531:.
509::
482:.
460::
433:.
421::
374:.
319:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.